Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Osteoboost, a targeted vibration therapy device, is now available to improve bone strength and bone density in postmenopausal women.

Discontinuing PJP prophylaxis while on prednisone doses greater than 12.5 mg per day may elevate infection risk among patients with rheumatic diseases.

From 2018 to 2021, the role of psychotherapy in outpatient mental health care increased, while psychotropic medication without psychotherapy became less common.

The use of HCQ among patients with SSc appears to be low and is not associated with improvements in hand function or activities of daily living.

Among children with Kawasaki disease, RDW-CV was identified as an independent predictor of CAD and was negatively correlated with markers of iron metabolism.

A low dose combination hormonal patch was found to be effective for pregnancy prevention based on results from a phase 3 study.

Use of a combined oral contraceptive (COC) is not associated with asthma in women of reproductive age, but use of a progestogen-only pill (POP) is associated with an increased risk for asthma attacks ...

Topline data were announced from two phase 3 trials evaluating MR-107A-02 for the treatment of moderate to severe acute pain.

Among patients with RA, ACPA status significantly modifies the relationship between BMI and cardiovascular risk.